Beta Drugs Limited has informed the Exchange regarding 'Secretarial Compliance Report for the period 1 April, 2024 to 31st October, 2025'.
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has submitted its Secretarial Compliance Report to the stock exchange for the period from 1 April 2024 to 31 October 2025. This is a routine regulatory filing where the company secretary certifies that the company has complied with applicable provisions of the Companies Act, SEBI regulations, and stock exchange listing requirements during the reporting period. The report covers roughly 18 months, suggesting a half-yearly compliance certification. The filing itself does not disclose any specific non-compliance or regulatory action.
This is a standard housekeeping compliance filing with no direct impact on share price or shareholders. It simply confirms the company is meeting its ongoing listing and regulatory obligations.